Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Pneumology Meets Oto-Rhino-Laryngology: A Discussion of Type 2 Inflammation in Airway Diseases

Hear from an expert on how do you manage treatment compliance issues in Patients with CRS with Nasal Polyps?

Hear From An Expert On The Type 2 Immune Response And Inflammation

Hear from an expert on Identifying Patients who are appropriate candidates for Biologic treatment

VTE Incidence after Cesarean Delivery in Selected Guidelines

Hear from an expert on what are the main challenges in treating Patients with CRS with Nasal Polyps?

Do historical HbA1c values explain glycemic legacy effect in type 2 diabetes?

Expert group consensus from the Arabian Peninsula on the diagnosis of LOPD

Diagnostic Algorithm for Gaucher Disease in Pediatric

Diagnostic Algorithm for Gaucher Disease in Adult

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

The superiority of Biologics over OCS for disease modifying potential which explains the superiority over OCS as anti-inflammatory option for our patients with CRSwNP, when we prescribe the Biologicals, we prescribe them long term for chronic disease where we do believe that we do not only aim to reduce inflammation but also to have some disease modifying effects.